Inogen Inc (NAS:INGN)
$ 8.61 -0.15 (-1.71%) Market Cap: 203.00 Mil Enterprise Value: 108.84 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 67/100

Inogen Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 04:45PM GMT
Release Date Price: $13 (+2.36%)
Mike Matson
Needham & Company, LLC - Analyst

Good afternoon. Thanks for joining us again at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the medtech equity research team at Needham & Company. I'm pleased to introduce Inogen.

Presenting today from Inogen, we have President and CEO, Nabil Shabshab; and CFO, Kristin Caltrider. Instead of a standard presentation, we're going to do a Q&A or a fireside chat session. If you do have any questions that you'd like to ask, you can submit them electronically through the Needham conference website. Or you can feel free to email them to me at [email protected], and I'll do my best to put them in.

So with that, Nabil, unless you want to make any introductory comments, we can go ahead and start with the questions.

Nabil Shabshab
Inogen, Inc. - President, CEO, & Director

Let's get started. Thank you for having us, Mike.

Questions & Answers

Mike Matson
Needham & Company, LLC - Analyst

Okay, yeah.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot